Boston Scientific recebe a aprovação da US FDA para o sistema de estimulação cerebral profunda Vercise ™

Boston Scientific Receives U.S. FDA Approval for the Vercise™ Deep Brain Stimulation System
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com

SOURCE Boston Scientific Corporation

Platform Offers Physicians Advanced Technology to Treat Symptoms of Parkinson's disease

MARLBOROUGH, Mass., Dec. 11, 2017 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for the Vercise™ Deep Brain Stimulation (DBS) System. DBS is used to treat the symptoms of Parkinson's disease (PD), a degenerative condition that affects more than one million people in the United States and 10 million worldwide.1 DBS works by stimulating a targeted region of the brain through implanted leads that are powered by a device called an implantable pulse generator (IPG). (segue...) Fonte: wboc.